MAIA Biotechnology, Inc. (MAIA)
1.325
+0.02
(+1.15%)
USD |
NYAM |
Sep 21, 16:00
1.33
0.00 (0.00%)
After-Hours: 20:00
MAIA Biotechnology Market Cap : 80.58M for Sept. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 79.67M |
| September 17, 2026 | 85.14M |
| September 16, 2026 | 85.14M |
| September 15, 2026 | 81.50M |
| September 14, 2026 | 84.54M |
| September 11, 2026 | 79.06M |
| September 10, 2026 | 79.67M |
| September 09, 2026 | 80.89M |
| September 08, 2026 | 79.67M |
| September 04, 2026 | 80.28M |
| September 03, 2026 | 80.89M |
| September 02, 2026 | 83.32M |
| September 01, 2026 | 79.06M |
| August 31, 2026 | 79.67M |
| August 28, 2026 | 80.89M |
| August 27, 2026 | 83.93M |
| August 26, 2026 | 84.54M |
| August 25, 2026 | 85.75M |
| August 24, 2026 | 82.10M |
| August 21, 2026 | 84.54M |
| August 20, 2026 | 83.93M |
| August 19, 2026 | 84.54M |
| August 18, 2026 | 83.32M |
| August 17, 2026 | 84.54M |
| August 14, 2026 | 85.14M |
| Date | Value |
|---|---|
| August 13, 2026 | 81.50M |
| August 12, 2026 | 83.93M |
| August 11, 2026 | 83.93M |
| August 10, 2026 | 85.75M |
| August 07, 2026 | 86.36M |
| August 06, 2026 | 86.36M |
| August 05, 2026 | 85.14M |
| August 04, 2026 | 82.51M |
| August 03, 2026 | 80.09M |
| July 31, 2026 | 75.84M |
| July 30, 2026 | 75.84M |
| July 29, 2026 | 72.81M |
| July 28, 2026 | 75.23M |
| July 27, 2026 | 77.66M |
| July 24, 2026 | 75.23M |
| July 23, 2026 | 77.66M |
| July 22, 2026 | 78.87M |
| July 21, 2026 | 80.69M |
| July 20, 2026 | 77.66M |
| July 17, 2026 | 78.87M |
| July 16, 2026 | 80.69M |
| July 15, 2026 | 89.19M |
| July 14, 2026 | 87.37M |
| July 13, 2026 | 86.15M |
| July 10, 2026 | 87.37M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals, Inc. | 82.55B |
| ACADIA Pharmaceuticals, Inc. | 4.543B |
| Alnylam Pharmaceuticals, Inc. | 32.66B |
| Anika Therapeutics, Inc. | 277.30M |
| Savara, Inc. | 1.120B |
Market Cap Related Metrics
| PEG Ratio | -0.2865 |
| Price to Book Value | 3.898 |
| Price | 1.325 |
| Earnings Yield | -47.83% |
| PEGY Ratio | -0.2865 |